Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma Marco K. C. HuiKenneth K. Y. LaiSimon Law Original Paper Open access 19 April 2012 Pages: 3009 - 3016
Docetaxel and cisplatin concurrent with radiotherapy versus 5-fluorouracil and cisplatin concurrent with radiotherapy in treatment for locally advanced oesophageal squamous cell carcinoma: a randomized clinical study Tao ZhaoHao ChenTingrong Zhang Original Paper 05 April 2012 Pages: 3017 - 3023
Expression of interleukin-17 and its clinical significance in gastric cancer patients Xin Ying MengChang Hong ZhouPing Ji Original Paper 29 June 2012 Pages: 3024 - 3028
Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine Jingwei YuJing GaoLin Shen Original Paper 06 July 2012 Pages: 3029 - 3034
Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancer Amir SonnenblickYakir RottenbergAyala Hubert Original Paper 08 July 2012 Pages: 3035 - 3038
C-KIT mutations were closely associated with the response to Imatinib in Chinese advanced gastrointestinal stromal tumor patients Jing GaoYunzhi DangLin Shen Original Paper 20 July 2012 Pages: 3039 - 3045
Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma Feifei LiWanhua RenChengyong Qin Original Paper 11 April 2012 Pages: 3046 - 3054
MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients Yousri M. HusseinFouad E. MoradNermin Raafat Original Paper 01 June 2012 Pages: 3055 - 3062
Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma Peng ZhouZhi ChenZhi-Ming Wang Original Paper 27 May 2012 Pages: 3063 - 3069
Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients Pin Dong LiWen Jie ZhangHui Yun Wang Original Paper 10 June 2012 Pages: 3070 - 3076
Involvement of discoidin domain 1 receptor in recurrence of hepatocellular carcinoma by genome-wide analysis Zhi-Xiang JianJian SunYi-Long Wu Original Paper 30 June 2012 Pages: 3077 - 3082
Tumor necrosis factor-α (TNF-α) stimulates the epithelial–mesenchymal transition regulator Snail in cholangiocarcinoma Anchalee TechasenNisana NamwatPuangrat Yongvanit Original Paper 19 August 2012 Pages: 3083 - 3091
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer De-shen WangHui-yan LuoRui-hua Xu Original Paper 05 April 2012 Pages: 3092 - 3100
Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer Ludmila Katherine MartinLai WeiTanios Bekaii-Saab Original Paper 24 June 2012 Pages: 3101 - 3107
Clinical significance of miR-22 expression in patients with colorectal cancer Guangjun ZhangShusen XiaTong Zhou Original Paper 11 April 2012 Pages: 3108 - 3112
The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer Mojin WangPeng ZhangXiaofeng Sun Original Paper 05 May 2012 Pages: 3113 - 3118
Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer Mevlüde İnançÖzlem ErFerhan Elmalı Original Paper 12 May 2012 Pages: 3119 - 3124
Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography Zeki UstunerO. Meltem AkayZafer Gulbas Original Paper 14 June 2012 Pages: 3125 - 3128
Association of plasma total and high-molecular-weight adiponectin with risk of colorectal cancer: an observational study in Chinese male Ming-Wei ChenShuai YeYou-Min Wang Original Paper 03 July 2012 Pages: 3129 - 3135
Expression of MSP58 in human colorectal cancer and its correlation with prognosis Hai ShiShu-Jun LiChang-Sheng Chen Original Paper Open access 08 July 2012 Pages: 3136 - 3142
New strategy in hepatic metastatic colorectal cancer: tomotherapy and capecitabine followed by hepatic surgical resection W. CacheuxM. A. BolletP. Mariani Short Communication 02 August 2012 Pages: 3143 - 3146
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients Emin Tamer ElkiranMehmet Ali KaplanAnatolian Society of Medical Oncology Group Original Paper 22 June 2012 Pages: 3147 - 3154
Desmoplastic malignant mesothelioma originating from the peritoneum Hiroyuki TakamaruYoshiaki ArimuraYasuhisa Shinomura Letter to the Editor 29 June 2012 Pages: 3155 - 3156
Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer Shidai JinWei ZhuRenhua Guo Original Paper 18 April 2012 Pages: 3157 - 3161
Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma Haofei WangWujun WangXuhui Gao Original Paper 22 April 2012 Pages: 3162 - 3168
Association between vascular-poor area of primary tumors and epidermal growth factor receptor gene status in advanced lung adenocarcinoma Yosuke TogashiKatsuhiro MasagoMichiaki Mishima Original Paper 11 April 2012 Pages: 3169 - 3175
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer Georg HolgerssonMartin SandelinMichael Bergqvist Original Paper 08 May 2012 Pages: 3176 - 3182
Expression and clinical significance of GRIM-19 in lung cancer Xiao-Yun FanZi-Feng JiangRong-Yu Liu Original Paper 10 May 2012 Pages: 3183 - 3189
Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients Han-Bo LeWang-Yu ZhuYong-Kui Zhang Original Paper 11 July 2012 Pages: 3190 - 3197
Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC Angela ZupaGiulia VitaGiuseppina Improta Original Paper 08 July 2012 Pages: 3198 - 3201
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group Hiroyuki NakamuraHiroaki SatohKinya Furukawa Original Paper 02 November 2012 Pages: 3202 - 3206
High expression of TIMP-1 in human breast cancer tissues is a predictive of resistance to paclitaxel-based chemotherapy Dongliang ZhuXiaoming ZhaYujie Sun Original Paper 29 April 2012 Pages: 3207 - 3215
Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case–control study Xin ZhouChengyi Wu Original Paper 26 April 2012 Pages: 3216 - 3221
Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients Guo-Chun ZhangXue-Ke QianNing Liao Original Paper 01 May 2012 Pages: 3222 - 3231
Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience Erkan DoganHikmet YorgunYavuz Ozisik Original Paper 22 May 2012 Pages: 3232 - 3239
Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer Minqing WuWeidong WeiXiaoming Xie Original Paper 04 June 2012 Pages: 3240 - 3249
Rural–urban disparities in use of post-lumpectomy radiation Steve R. MartinezDhruvil R. ShahRichard J. Bold Original Paper 09 June 2012 Pages: 3250 - 3257
Inhibition of phosphoinositide 3-kinase enhances the cytotoxicity of AG1478, an epidermal growth factor receptor inhibitor, in breast cancer cells Ping LiArtour TorossianShen Fu Original Paper 23 June 2012 Pages: 3258 - 3264
Long-term effect of trastuzumab on QT dispersion in adjuvant treatment for patients with Her2 receptor positive breast cancer: a pilot study Ozgur TanriverdiNezih MeydanSabri Barutca Original Paper 30 June 2012 Pages: 3265 - 3271
BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity Abida JuwleDhananjaya Saranath Original Paper 03 July 2012 Pages: 3272 - 3281
Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression Fausto PetrelliSandro Barni Review Article 28 July 2012 Pages: 3282 - 3290
Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI Kwonoh ParkJae-Lyun LeeHanjong Ahn Original Paper 30 March 2012 Pages: 3291 - 3297
Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinoma Atsunari KawashimaAkira TsujimuraThe Osaka Renal Cell Carcinoma Clinical Study Collaboration Original Paper 29 April 2012 Pages: 3298 - 3305
Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion Jian-Jun MaLing-Min KongTing-Yi Bao Original Paper 13 June 2012 Pages: 3306 - 3313
Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database Alexandr PoprachZbyněk BortlíčekJakub Gregor Original Paper 30 June 2012 Pages: 3314 - 3320
Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma Tomas BuchlerTomas PavlikBohuslav Melichar Short Communication 30 June 2012 Pages: 3321 - 3324
Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma Guangning ZhaoYuming YangYan Sun Original Paper 03 August 2012 Pages: 3325 - 3334
A coincidence of renal cell carcinoma and hematological malignancies Gokhan SargınIrfan YavasogluZahit Bolaman Letter to the Editor 29 July 2012 Pages: 3335 - 3338
Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer Qiang FuJudd W. MoulThomas J. Polascik Original Paper 12 June 2012 Pages: 3339 - 3344
Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer Sanaa EissaHanan ShehataOmar El-Ahmady Original Paper 04 July 2012 Pages: 3345 - 3351